Healthcare provider profile · identity verified

Inderjot Bajwa

Internal Medicine · EVERETT, WA · NPI 1720466980

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	936	313
Amlodipine Besylate	Amlodipine Besylate	443	140
Levothyroxine Sodium	Levothyroxine Sodium	416	110
Losartan Potassium	Losartan Potassium	391	126
Lisinopril	Lisinopril	300	99
Omeprazole	Omeprazole	260	92
Gabapentin	Gabapentin	234	75
Metoprolol Succinate	Metoprolol Succinate	226	83
Tamsulosin Hcl	Tamsulosin Hcl	211	65
Rosuvastatin Calcium	Rosuvastatin Calcium	208	78
Pantoprazole Sodium	Pantoprazole Sodium	207	67
Alendronate Sodium	Alendronate Sodium	189	55
Furosemide	Furosemide	173	50
Metformin Hcl Er	Metformin Hcl	166	63
Albuterol Sulfate Hfa	Albuterol Sulfate	148	68
Hydrochlorothiazide	Hydrochlorothiazide	148	57
Trazodone Hcl	Trazodone Hcl	146	44
Sertraline Hcl	Sertraline Hcl	144	40
Jardiance	Empagliflozin	138	42
Potassium Chloride	Potassium Chloride	123	43
Fluticasone Propionate	Fluticasone Propionate	118	58
Citalopram Hbr	Citalopram Hydrobromide	113	27
Simvastatin	Simvastatin	109	33
Duloxetine Hcl	Duloxetine Hcl	99	27
Atenolol	Atenolol	97	31
Clopidogrel	Clopidogrel Bisulfate	95	25
Allopurinol	Allopurinol	91	30
Famotidine	Famotidine	91	30
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	81	suppressed
Finasteride	Finasteride	75	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	19
Glipizide Er	Glipizide	71	29
Bupropion Xl	Bupropion Hcl	70	23
Metoprolol Tartrate	Metoprolol Tartrate	69	25
Escitalopram Oxalate	Escitalopram Oxalate	68	16
Ozempic	Semaglutide	66	14
Mirtazapine	Mirtazapine	63	18
Pregabalin	Pregabalin	62	20
Tizanidine Hcl	Tizanidine Hcl	62	29
Carvedilol	Carvedilol	59	22
Acyclovir	Acyclovir	58	14
Pravastatin Sodium	Pravastatin Sodium	57	21
Baclofen	Baclofen	53	11
Metformin Hcl	Metformin Hcl	51	21
Montelukast Sodium	Montelukast Sodium	51	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	19
Ropinirole Hcl	Ropinirole Hcl	48	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	48	33
Quetiapine Fumarate	Quetiapine Fumarate	46	14
Buspirone Hcl	Buspirone Hcl	45	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	21
Prednisone	Prednisone	45	32
Eliquis	Apixaban	43	suppressed
Glipizide	Glipizide	42	suppressed
Spironolactone	Spironolactone	42	17
Venlafaxine Hcl Er	Venlafaxine Hcl	41	13
Ezetimibe	Ezetimibe	40	11
Fluoxetine Hcl	Fluoxetine Hcl	39	11
Tramadol Hcl	Tramadol Hcl	39	11
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Lidocaine	Lidocaine	34	15
Ondansetron Odt	Ondansetron	34	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Colchicine	Colchicine	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Torsemide	Torsemide	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	11
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Ketoconazole	Ketoconazole	23	12
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Estradiol	Estradiol	21	13
Fluconazole	Fluconazole	21	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Clotrimazole	Clotrimazole	20	11
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Methimazole	Methimazole	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Azithromycin	Azithromycin	15	15
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Alprazolam	Alprazolam	14	12
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nitroglycerin	Nitroglycerin	14	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Modafinil	Modafinil	13	suppressed
Naproxen	Naproxen	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Topiramate	Topiramate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Nystatin	Nystatin	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error